Browse by Journal Title

2023

Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis.
Brune-Ingebretsen, S., Høgestøl, E.A., de Rosbo, N.K., Berg-Hansen, P., Brunborg, C., Blennow, K., Zetterberg, H., Paul, F., Uccelli, A., Villoslada, P., Harbo, H.F and Berge, T.
Journal of Neuroimmunology 382 : 578175. 15 September 2023

2022

CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.
Fuchs, L., Mausner-Fainberg, K., Luban, A., Asseyer, S.E., Golan, M., Benhamou, M., Volovitz, I., Regev, K., Vigiser, I., Piura, Y., Kolb, H., Paul, F. and Karni, A.
Journal of Neuroimmunology 371 : 577936. 15 October 2022

2021

C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.
Pache, F., Ringelstein, M., Aktas, O., Kleiter, I., Jarius, S., Siebert, N., Bellmann-Strobl, J., Paul, F. and Ruprecht, K.
Journal of Neuroimmunology 360 : 577699. 15 November 2021

2020

Binding patterns and functional properties of human antibodies to AQP4 and MOG on murine optic nerve and retina.
Faissner, S., Graz, F., Reinehr, S., Petrikowski, L., Haupeltshofer, S., Ceylan, U., Stute, G., Winklmeier, S., Pache, F., Paul, F., Ruprecht, K., Meinl, E., Dick, H.B., Gold, R., Kleiter, I. and Joachim, S.C.
Journal of Neuroimmunology 342 : 577194. 15 May 2020

2019

Sodium chloride triggers Th17 mediated autoimmunity.
Haase, S., Wilck, N., Kleinewietfeld, M., Müller, D.N. and Linker, R.A.
Journal of Neuroimmunology 329 : 9-13. 15 April 2019

2016

Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: a peptide microarray-based case-control study.
Schlemm, L., Giess, R.M., Rasche, L., Pfuhl, C., Wakonig, K., Behrens, J.R., Scheibenbogen, C., Bellmann-Strobl, J., Paul, F., Reimer, U. and Ruprecht, K.
Journal of Neuroimmunology 297 : 56-62. 15 August 2016

Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.
Miyaji, K., Paul, F., Shahrizaila, N., Umapathi, T. and Yuki, N.
Journal of Neuroimmunology 291 : 78-81. 15 February 2016

2015

Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis.
Pfuhl, C., Oechtering, J., Rasche, L., Gieß, R.M., Behrens, J.R., Wakonig, K., Freitag, E., Pache, F.C., Otto, C., Hofmann, J., Eberspächer, B., Bellmann-Strobl, J., Paul, F. and Ruprecht, K.
Journal of Neuroimmunology 285 : 156-160. 15 August 2015

Toxoplasma gondii seropositivity is negatively associated with multiple sclerosis.
Stascheit, F., Paul, F., Harms, L. and Rosche, B.
Journal of Neuroimmunology 285 : 119-124. 15 August 2015

2014

Complement regulatory proteins (CD46, 55 and 59) expressed on Schwann cells: Immune targets in demyelinating neuropathies?
Miyaji, K., Paul, F., Shahrizaila, N., Umapathi, T. and Yuki, N.
Journal of Neuroimmunology 276 (1-2): 172-174. November 2014

Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Ruprecht, K., Wunderlich, B., Gieß, R., Meyer, P., Loebel, M., Lenz, K., Hofmann, J., Rosche, B., Wengert, O., Paul, F., Reimer, U. and Scheibenbogen, C.
Journal of Neuroimmunology 272 (1-2): 56-61. 15 July 2014

2013

The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Fiebiger, S.M., Bros, H., Grobosch, T., Janssen, A., Chanvillard, C., Paul, F., Dörr, J., Millward, J.M. and Infante-Duarte, C.
Journal of Neuroimmunology 262 (1-2): 66-71. 15 September 2013

Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Hamann, I., Dörr, J., Glumm, R., Chanvillard, C., Janssen, A., Millward, J.M., Paul, F., Ransohoff, R.M. and Infante-Duarte, C.
Journal of Neuroimmunology 254 (1-2): 165-169. 15 January 2013

2010

Dysregulated Epstein-Barr virus infection in patients with CIDP.
Luenemann, J.D., Tackenberg, B., Stein, A., Wandinger, K.P., Oertel, W.H., Wagner, H.J., Muenz, C., Meisel, H., Sommer, N. and Zipp, F.
Journal of Neuroimmunology 218 (1-2): 107-111. 25 January 2010

2009

Neuroprotection and enhanced neurogenesis by extract from the tropical plant Knema laurina after inflammatory damage in living brain tissue.
Haeke, I., Schoenenberger, S., Neumann, J., Franke, K., Paulsen-Merker, K., Reymann, K., Ismail, G., Bin Din, L., Said, I.M., Latiff, A., Wessjohann, L., Zipp, F. and Ullrich, O.
Journal of Neuroimmunology 206 (1-2): 91-99. 3 January 2009

2007

Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
Aktas, O., Waiczies, S. and Zipp, F.
Journal of Neuroimmunology 184 (1-2): 17-26. March 2007

Special issue on inflammation, neurodegeneration and neuroprotection in the central nervous system - Introduction.
Zipp, F. and Trapp, B.D.
Journal of Neuroimmunology 184 (1-2): 1-3. March 2007

2004

Production of neuroprotective NGF in astrocyte-T helper cell cocultures is upregulated following antigen recognition.
Oren, A., Falk, K., Roetzschke, O., Bechmann, I., Nitsch, R. and Gimsa, U.
Journal of Neuroimmunology 149 (1-2): 59-65. April 2004

2002

Elevated Bcl-X(L) levels correlate with T cell survival in multiple sclerosis.
Waiczies, S., Weber, A., Luenemann, J.D., Aktas, O., Zschenderlein, R. and Zipp, F.
Journal of Neuroimmunology 126 (1-2): 213-220. May 2002

Induction of TRAIL-mediated glioma cell death by human T cells.
Doerr, J., Waiczies, S., Wendling, U., Seeger, B. and Zipp, F.
Journal of Neuroimmunology 122 (1-2): 117-124. January 2002

2001

Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis.
Aktas, O., Waiczies, S., Grieger, U., Wendling, U., Zschenderlein, R. and Zipp, F.
Journal of Neuroimmunology 114 (1-2): 160-167. 1 March 2001

2000

Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells.
Zipp, F., Wendling, U., Beyer, M., Grieger, U., Waiczies, S., Wagenknecht, B., Haas, J. and Weller, M.
Journal of Neuroimmunology 110 (1-2): 214-222. 2 October 2000

1997

Highly purified oligo-His tagged human recombinant alpha(1)-AChR is immunogenic in vivo and suitable for T cell stimulation in vitro in experimental and human myasthenia gravis.
Voltz, R., Kamm, C., Padberg, F., Malotka, J., Kerschensteiner, M., Spuler, S., Tzartos, S. and Dornmair, K.
Journal of Neuroimmunology 80 (1-2): 131-136. December 1997

1996

Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity.
Spuler, S., Yousry, T., Scheller, A., Voltz, R., Holler, E., Hartmann, M., Wick, M. and Hohlfeld, R.
Journal of Neuroimmunology 66 (1-2): 57-64. May 1996

1994

A potential role for human herpesvirus type 6 in nervous system disease.
Wilborn, F., Schmidt, C.A., Brinkmann, V., Jendroska, K., Oettle, H. and Siegert, W.
Journal of Neuroimmunology 49 (1-2): 213-214. 1 January 1994